Anzeige
Mehr »
Login
Donnerstag, 24.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
KI-Energiekrise: Wie dieser Small Cap die nukleare Zukunft des Silicon Valley befeuern könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EYNB | ISIN: DK0062502894 | Ticker-Symbol: 1TB0
Frankfurt
24.10.24
08:05 Uhr
144,50 Euro
0,00
0,00 %
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
STRATEGIC PARTNERS A/S Chart 1 Jahr
5-Tage-Chart
STRATEGIC PARTNERS A/S 5-Tage-Chart
RealtimeGeldBriefZeit
144,50152,5016:55

Aktuelle News zur STRATEGIC PARTNERS A/S Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:34Nasdaq Welcomes Strategic Partners A/S to Nasdaq Copenhagen Main Market194Copenhagen, October 24, 2024?- Nasdaq (Nasdaq: NDAQ) announces that trading in Strategic Partners shares (ticker name: STRAP) will commence today on the Nasdaq Copenhagen Main Market. Strategic Partners...
► Artikel lesen
DiNasdaq Copenhagen A/S: Orphazyme A/S - name change to Strategic Partners A/S118The changes below will take effect on Nasdaq Copenhagen as per 24 October 2024. ISIN: DK0062502894 ------------------------------------------- Name Orphazyme ------------------------------------------- New...
► Artikel lesen
23.09.First North Denmark: Orphazyme A/S - admittance to trading and official listing of new shares173The share capital of Orphazyme A/S has been increased due to a directed issue. The admittance to trading and official listing will take effect as per 24 September 2024 in the ISIN below. ISIN: ...
► Artikel lesen
23.09.Nasdaq Copenhagen A/S: Orphazyme A/S - Observation status removed113Nasdaq Copenhagen has today removed observation status for: ISIN Name DK0062502894 ORPHAZYME The company's observation status is removed because the company's change of identity...
► Artikel lesen
10.01.Nasdaq Copenhagen A/S: Orphazyme A/S - reduction of share capital by reduction of face value361The changes below will take effect on Nasdaq Copenhagen as per 12 January 2024. ISIN DK0062502894 -------------------------------------------------------------------- Name:...
► Artikel lesen
06.12.23XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 06.12.2023585The following instruments on XETRA do have their first trading 06.12.2023 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 06.12.2023 Aktien 1 US1468756044 Carver Bancorp Inc. 2...
► Artikel lesen
05.12.23XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.12.2023933The following instruments on Boerse Frankfurt do have their last trading day on 05.12.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.12.2023ISIN NameAU000000FYI5 FYI...
► Artikel lesen
05.12.23XFRA ISIN CHANGE771Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenAU000000FYI5 Cadoux Ltd. 05.12.2023 AU0000310302 Cadoux Ltd. 06.12.2023 Tausch 1:1KYG2007L2040 Cazoo Group Ltd. 05.12.2023...
► Artikel lesen
05.12.23XFRA CAPITAL ADJUSTMENT INFORMATION - 05.12.2023847Das Instrument 8QE KYG2007L2040 CAZOO GROUP A DL-,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 05.12.2023 und ex Kapitalmassnahme am 06.12.2023 The instrument 8QE KYG2007L2040 CAZOO GROUP A DL-...
► Artikel lesen
01.12.23Nasdaq Copenhagen A/S: Orphazyme A/S - reversed stock split - new ISIN633As per 6 December 2023 the par value of the shares issued by Orphazyme A/S will be changed and consequently the ISIN will be changed due to a reversed stock split. At the same time, the company's share...
► Artikel lesen
08.11.23Notice of Extraordinary General Meeting in Orphazyme A/S262The board of directors hereby convenes for an extraordinary general meeting in Orphazyme A/S at the company's address at Lyskjær 8A, 2730 Herlev on Thursday 30 November 2023 at 10.00 AM (CET). Agenda:...
► Artikel lesen
08.11.23Orphazyme A/S: Business update October 2023342Unless otherwise stated, comments in this announcement refer to performance from continuing operations from 1 January - 31 October 2023. Net loss for the 10 months ended October 2023 totaled DKK 29...
► Artikel lesen
02.11.23Orphazyme A/S: Process for reverse share split at a consolidation ratio of 1.000:1237At the company's extraordinary general assembly November 2nd 2023 it was decided to implement a reverse share split at a consolidation ratio of 1.000:1, see company announcement 18/2023. The reverse...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1